Results 271 to 280 of about 4,521,628 (366)
Human papillomavirus vaccination at the national level in Tunisia: a cost-effectiveness analysis using a comparative modeling study [PDF]
Oumaima Laraj +5 more
openalex +1 more source
Diffusion‐Weighted Imaging for the Evaluation of the Sacroiliac Joint in Pediatric Patients
Objective Maturational signal in the sacroiliac joint (SIJ) of skeletally immature youth is often misinterpreted as inflammation. Diagnostic tools that improve specificity are greatly needed. Apparent diffusion coefficient (ADC) values from diffusion‐weighted imaging (DWI), when used with standard imaging, may enhance diagnostic accuracy.
Michael L. Francavilla +6 more
wiley +1 more source
Correction: Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma. [PDF]
Zhu Y +6 more
europepmc +1 more source
Financial Distress and Its Determinants in Rheumatoid Arthritis
Objective To quantify the degree of financial distress and identify its determinants in adults with rheumatoid arthritis (RA) given the frequent prolonged use of expensive disease‐modifying therapies. Methods We identified adults enrolled in the FORWARD databank with either RA or noninflammatory musculoskeletal disease (NIMSKD) completing the ...
Amber Brown Keebler +5 more
wiley +1 more source
Intradermal hepatitis B vaccination with imiquimod pretreatment in dialysis patients: a cost-effectiveness analysis. [PDF]
Wang Y, Rui M, You JHS.
europepmc +1 more source
Cost-Effectiveness Analysis of the Residential Provisions of the 2015 IECC for Montana
Vrushali V. Mendon +3 more
openalex +2 more sources
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma. [PDF]
Zhu Y +6 more
europepmc +1 more source

